News

Viewbix Moves to Strengthen Position through Quantum X Labs Acquisition

Viewbix Moves to Strengthen Position through Quantum X Labs Acquisition

Viewbix’s Strategic Acquisition of Quantum X Labs

Company Signs Non-Binding Term Sheet for Acquisition

Viewbix Inc. (NASDAQ: VBIX), a prominent player in the digital advertising technology sector, has made headlines by announcing its intention to acquire Quantum X Labs Ltd. This move is aimed at bolstering Viewbix's commitment to advancing technology in quantum computing and artificial intelligence. The signing of a non-binding term sheet signifies the start of this significant acquisition process.

Details of the Acquisition Agreement

The acquisition will involve Viewbix acquiring 100% of Quantum X Labs’ share capital. In return, the shareholders of Quantum X Labs will receive a combination of shares and pre-funded warrants for Viewbix's common stock. This exchange will represent approximately 65% of Viewbix's total post-acquisition share capital. Additionally, the deal will incorporate a private investment in public equity (PIPE) financing amounting to $3 million.

The Vision of Quantum X Labs

Quantum X Labs stands out as a leader in the field of quantum computing and AI. This innovative company focuses on pioneering technologies in quantum algorithmics and physics. By fostering a rich ecosystem, Quantum X Labs not only develops advanced solutions but also holds an array of patents protecting its unique technologies. It aims to push the boundaries of quantum innovations across various sectors.

Upcoming Steps for the Acquisition

The completion of the acquisition is projected for December, pending necessary due diligence, definitive agreements, regulatory approvals, and the agreement of Viewbix shareholders. This careful process underscores Viewbix's strategic approach, ensuring that all aspects align with compliance and stakeholder interests.

About Viewbix Inc.

Viewbix, through its subsidiaries Gix Media Ltd. and Cortex Media Group Ltd., specializes in digital advertising. The company operates within two primary domains: search and digital content. Its search division is dedicated to creating sophisticated software solutions aimed at optimizing internet campaigns and efficiently directing user traffic to clients. Meanwhile, the digital content division is focused on producing engaging material targeted at varied audiences. This approach not only allows for generating advertising revenues from major platforms, like Google and Facebook, but also maximizes profitability for clients.

The Future of Quantum Computing with Viewbix

This acquisition is more than a transaction; it is a transformative step for Viewbix towards the future of technology. By integrating Quantum X Labs’ advanced capabilities, Viewbix is poised to enhance its technological offerings, paving the way for further innovations in digital advertising and quantum technology. This strategic move may well position Viewbix as a formidable competitor in the ever-evolving tech landscape.

Investor Relations and Further Information

For any queries or further details regarding this exciting acquisition, investors and interested parties are encouraged to connect with Viewbix’s investor relations team. The company is committed to maintaining transparency and open communication throughout this process, underscoring its dedication to stakeholders.

Frequently Asked Questions

What is the focus of Quantum X Labs?

Quantum X Labs specializes in quantum computing and AI, developing advanced technologies to advance quantum innovations.

When is the acquisition of Quantum X Labs expected to close?

The acquisition is expected to close in December, pending necessary approvals and due diligence.

What percentage of the outstanding shares will be distributed to Quantum X Labs shareholders?

Shareholders of Quantum X Labs will receive shares and warrants amounting to 65% of Viewbix's total post-acquisition capital.

How does Viewbix's technology benefit advertisers?

Viewbix provides tools that help advertisers optimize their campaigns and increase revenue through enhanced user engagement and traffic acquisition.

Who can I contact for more information about Viewbix?

For inquiries, you can reach out to Michal Efraty at the investor relations contact provided in the announcement.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 1

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 5

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 1

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 3

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 8

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 1

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 8

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading

Top 5 Most Recently Viewed Articles

92,000 SF Leased in Frederick: Matan Clinches Deals

Updated Category News Views 30

Trudging through the week, I caught wind of a deal shaking up the industrial real estate sector in Frederick, Maryland. Matan Companies, a big name in the industrial development game, has bagged two hefty leases that throw more than 92,000 square feet on their already impressive portfolio board. If you've ever doubted Frederick's allure, these deals slap that skepticism...

Continue Reading
Kestrel Group Reports Positive Q2 2025 Financial Performance

Updated Category News Views 195

Kestrel Group Delivers Second Quarter Financial Results Kestrel Group Ltd (NASDAQ: KG) has recently unveiled its financial performance for the second quarter that wrapped up mid-year. The company's effective strategies are reflected in its ongoing financial stability and growth trajectory. Key Financial Highlights for the Quarter In the latest financial disclosure,...

Continue Reading
Oxbridge Re Holdings Discusses Innovation in RWA Tokenization

Updated Category News Views 175

Exciting Developments at ETHDenver 2025 Oxbridge Re Holdings Limited (NASDAQ: OXBR), a pioneering company in the tokenization of Real-World Assets (RWAs), is gearing up for an exciting event at ETHDenver 2025. With its subsidiary, SurancePlus, the company operates at the forefront of merging blockchain technology with reinsurance, enhancing investment opportunities for...

Continue Reading
Ameren Corporation's Strategic Move with New Senior Notes

Updated Category News Views 287

Ameren Corporation's Senior Notes Pricing Announcement Ameren Corporation (NYSE: AEE) has made headlines with its recent announcement of the pricing for a public offering of senior notes. This strategic financial maneuver involves an impressive $750 million of 5.375% senior notes, due in 2035. The offering, which is priced at 99.822% of the principal amount, is poised to...

Continue Reading
Inari Medical Revolutionizes Arteriovenous Treatment with InThrill

Updated Category News Views 123

Inari Medical Unveils Revolutionary InThrill Thrombectomy System Inari Medical, a valued subsidiary of Stryker (NYSE: SYK), has introduced the InThrill Thrombectomy System, a groundbreaking solution designed specifically for arteriovenous access and small vessel thrombus procedures. This innovative system stands as the first and only dedicated tool tailored for fast and...

Continue Reading